Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide
Journal of the National Cancer Institute Dec 11, 2018
Walpole S, et al. - Researchers attempted to better characterize the genotypes and phenotypes associated with the BRCA1-associated protein-1 (BAP1) tumor predisposition syndrome (BAP1-TPDS), which is a hereditary tumor syndrome, given that it is important to acquire improved understanding of the BAP1-TPDS to ensure appropriate clinical management of BAP1 germline variant carriers and their families. They analyzed data for 106 published and 75 unpublished BAP1 germline variant-positive families worldwide. The core tumor spectrum associated with the BAP1-TPDS was corroborated by the collated data. In addition, data revealed that this phenotype could be seen in some families carrying missense variants. Families of variant carriers had a variety of noncore BAP1-TPDS -associated tumors. For all tumors combined, mesothelioma, cutaneous melanoma, and nonmelanoma skin cancer, lower median ages of onset of core tumor types were observed in null vs missense variant carriers.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries